Adam Davidson, CEO of Trident Royalties, discusses offtake milestones and catalysts to boost FY24. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDiscoverIE Regulatory News (DSCV)

Share Price Information for DiscoverIE (DSCV)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 746.00
Bid: 744.00
Ask: 746.00
Change: 0.00 (0.00%)
Spread: 2.00 (0.269%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 746.00
DSCV Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Update

9 Feb 2021 07:00

RNS Number : 3732O
discoverIE Group plc
09 February 2021
 

For Release

7.00am, 9 February 2021

 

discoverIE Group plc

 

Trading Update

 

Good trading momentum continues

 

 

discoverIE Group plc (LSE: DSCV, "discoverIE" or the "Group"), a leading international designer, manufacturer and supplier of customised electronics to industry, today issues a trading update covering the four month period to 31 January 2021.

 

Trading has continued to strengthen with underlying earnings for the full year ending 31 March 2021 expected to be towards the upper end of market expectations.

 

Order intake in the period has been strong, with both Group and divisional orders increasing by 10% organically(1) over the prior year's pre COVID-19 levels and with a Group book to bill ratio of 1.17:1. This represents a significant improvement on the first half of the year (H1 Group orders: 18% lower; book to bill: 0.91:1), as the COVID-19 recovery strengthened and trading momentum increased. The Group order book has increased to £162m, 2% ahead of last year at CER(2) and a sequential increase of 14% organically since the end of the first half.

 

Sales also showed positive momentum: Group average monthly sales increased by 4% compared with the first half, while sales in our target markets, which account for 69% of Group sales, grew well ahead of other markets and returned to organic growth. As a result, Group sales for the period were 5% lower year-on-year organically, having been 8% lower in the first half. This improvement was evident across both divisions: sales in D&M, which were 67% of Group sales, reduced by 3% organically (H1: 7% lower) while in Custom Supply, sales reduced by 10% organically (H1: 11% lower). During the period, gross margins have remained firm and tight control of operating expenses has continued.

 

Year to date, Group orders and sales are lower by 5% CER, by 4% on a reported basis and by 7% organically.

 

Phoenix America Inc ("Phoenix"), which was acquired in October 2020, is performing well and in line with expectations. Its sales were ahead of last year and its integration into the Variohm Group is progressing well. The acquisition of Limitor GmbH ("Limitor") which was announced in December 2020, is expected to complete this month.

 

The Group remains well funded with good liquidity. Cash flow during the period has continued to be strong with gearing(3) at the period end reducing to 1.1x from a proforma gearing (including Phoenix) of 1.2x at 30 September 2020. Including the Limitor acquisition, proforma gearing at the period end was 1.35x, below our target gearing range of 1.5x to 2.0x with significant headroom remaining for further acquisitions.

 

The recovery through the second half to date and the strong order momentum provides a solid base from which to return to Group wide organic sales growth and underpins the expected progress into the next financial year. With a clear strategy focused on long-term high quality growth markets, a strong funnel of design wins and acquisition targets, the Group is well positioned to make further progress.

 

 

 

 

 

 

 

 

For further information, please contact:

 

discoverIE Group plc 01483 544 500

Nick Jefferies Group Chief Executive

Simon Gibbins Group Finance Director

 

Buchanan 020 7466 5000

Chris Lane, Toto Berger, Charlotte Slater

discoverIE@buchanan.uk.com

 

 

 

 

 

 

Notes

1. Growth rates refer to the comparable prior year period unless stated. Organic growth for the Group is calculated at CER and is shown excluding the first 12 months of acquisitions post completion (Sens-Tech was acquired on 16 October 2019 and Phoenix on 14 October 2020).

 

2. Growth rates at constant exchange rates ("CER"). The average sterling rate of exchange against the Euro for the period weakened by 5% compared with the average rate for the same period last year, and by 5% on average against the three Nordic currencies, while strengthening by 3% compared with the US dollar rate for last year.

3. Gearing ratio is defined as net debt divided by underlying EBITDA (annualised for acquisitions). Gearing of 1.0x was reported at H1 2020/21 with proforma gearing of 1.2x including the acquisition of Phoenix in October 2020.

 

4. This trading update is based upon unaudited management accounts and has been prepared solely to provide additional information on trading to the shareholders of discoverIE Group plc. It should not be relied on by any other party for other purposes. Certain statements made in this update are forward looking statements. Such statements have been made by the Directors in good faith using information available up until the date that they approved this update. Forward looking statements should be regarded with caution because of the inherent uncertainties in economic trends and business risks.

 

 

Notes to Editors:

 

About discoverIE Group plc

 

discoverIE Group plc is an international group of businesses that designs, manufactures and supplies innovative components for electronic applications.

 

The Group provides application-specific components to original equipment manufacturers ("OEMs") internationally. By designing components that meet customers' unique requirements, which are then manufactured and supplied throughout the life of their production, a high level of repeating revenue is generated with long term customer relationships.

 

With a focus on key markets driven by structural growth and increasing electronic content, namely renewable energy, transportation, medical and industrial & connectivity, the Group aims to achieve organic growth that is well ahead of GDP and to supplement that with targeted complementary acquisitions. The Group has an ongoing commitment to reducing the impact of its operations on the environment, while its key markets are aligned with a sustainable future.

 

The Group employs c.4,200 people and its principal operating units are located in Continental Europe, the UK, China, Sri Lanka, India and North America.

 

The Group is listed on the Main Market of the London Stock Exchange and is in the top quartile of the FTSE Small Cap Index, classified within the Electrical Components and Equipment subsector, and has revenues of over £450m.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTFLFERFFITIIL
Date   Source Headline
18th Apr 20247:00 amRNSFull Year Trading Update
28th Mar 20247:30 amRNSDirector Declaration
22nd Mar 20248:09 amRNSNotification of Major Holdings
20th Mar 20243:45 pmRNSDirector/PDMR Shareholding
14th Mar 20241:21 pmRNSDirector/PDMR Shareholding
19th Feb 20244:07 pmRNSDirector/PDMR Shareholding
6th Feb 20247:00 amRNSTrading Update
29th Jan 202410:31 amRNSDirector / PDMR Shareholding
8th Jan 20248:41 amRNSNotification of Major Holdings
4th Jan 20244:03 pmRNSNotification of Major Holdings
21st Dec 20233:57 pmRNSNotification of Major Holdings
13th Dec 20239:03 amRNSNotification of Major Holdings
8th Dec 202310:52 amRNSNotification of Major Holdings
5th Dec 20237:00 amRNSInterim Results
22nd Nov 20238:30 amRNSNotice of Interim Results
11th Oct 20237:00 amRNSFirst Half Trading Update
15th Sep 20239:11 amRNSDirector/PDMR Shareholding
13th Sep 20237:00 amRNSAcquisition of 2J Antennas Group
5th Sep 20232:17 pmRNSNotification of Major Holdings
31st Aug 20237:00 amRNSAcquisition completion - Silvertel
1st Aug 20237:00 amRNSAcquisition of Silvertel
24th Jul 20232:31 pmRNSResults of Annual General Meeting
24th Jul 20237:00 amRNSTrading Update
27th Jun 202310:53 amRNSDirector / PDMR Shareholding
27th Jun 202310:47 amRNSNotification of Major Holdings
22nd Jun 202312:35 pmRNSAnnual Report & Notice of AGM
19th Jun 20238:35 amRNSNotification of Major Holdings
15th Jun 20239:51 amRNSDirector LTIP Award
7th Jun 20237:00 amRNSPreliminary results
1st Jun 20232:50 pmRNSNotification of Major Holdings
30th May 20237:00 amRNSAppointment of Non-Executive Director
18th May 20231:33 pmRNSNotification of Major Holdings
17th May 202310:25 amRNSNotice of Full Year Results
19th Apr 20237:00 amRNSFull Year Trading Update
18th Apr 20237:00 amRNSNotification of Major Holdings
29th Mar 20235:47 pmRNSNotification of Major Holdings
15th Mar 20233:53 pmRNSNotification of Major Holdings
15th Mar 20238:37 amRNSNotification of Major Holdings
15th Mar 20237:00 amRNSNotification of Major Holdings
23rd Feb 20232:58 pmRNSNotification of Major Holdings
20th Feb 20239:48 amRNSNotification of Major Holdings
15th Feb 20235:33 pmRNSNotification of Major Holdings
13th Feb 202311:36 amRNSNotification of Major Holdings
25th Jan 20237:00 amRNSQ3 Trading Update and Acquisition Completion
6th Jan 20231:41 pmRNSNotification of Major Holdings
6th Jan 20238:24 amRNSNotification of Major Holdings
3rd Jan 202310:38 amRNSNotification of Major Holdings
22nd Dec 20227:00 amRNSAcquisition of Magnasphere Corporation
14th Dec 20224:31 pmEQSParadigm Biopharmaceuticals (PAR): Adapted therapies to meet unmet demand
5th Dec 20229:53 amEQSdiscoverIE Group (DSCV): Focused on sustainable growth

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.